Ana
Vega Gliemmo
Keio University
Tokio, JapónPublicaciones en colaboración con investigadores/as de Keio University (1)
2018
-
Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and breast/ovarian) cancer susceptibility genes: An international survey by the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) clinical working group
JCO Precision Oncology, Vol. 2